0001104659-22-124100.txt : 20221202 0001104659-22-124100.hdr.sgml : 20221202 20221202161402 ACCESSION NUMBER: 0001104659-22-124100 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20221130 FILED AS OF DATE: 20221202 DATE AS OF CHANGE: 20221202 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Jin David CENTRAL INDEX KEY: 0001930732 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-35366 FILM NUMBER: 221442084 MAIL ADDRESS: STREET 1: C/O AVENUE THERAPEUTICS, INC. STREET 2: 1140 AVENUE OF THE AMERICAS, FLOOR 9 CITY: NEW YORK STATE: NY ZIP: 10036 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Fortress Biotech, Inc. CENTRAL INDEX KEY: 0001429260 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 205157386 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 1111 KANE CONCOURSE STREET 2: SUITE 301 CITY: BAY HARBOR ISLANDS STATE: FL ZIP: 33154 BUSINESS PHONE: 781-652-4500 MAIL ADDRESS: STREET 1: 1111 KANE CONCOURSE STREET 2: SUITE 301 CITY: BAY HARBOR ISLANDS STATE: FL ZIP: 33154 FORMER COMPANY: FORMER CONFORMED NAME: CORONADO BIOSCIENCES INC DATE OF NAME CHANGE: 20080310 4 1 tm2231877-1_4seq1.xml OWNERSHIP DOCUMENT X0306 4 2022-11-30 0 0001429260 Fortress Biotech, Inc. FBIO 0001930732 Jin David C/O FORTRESS BIOTECH, INC. 1111 KANE CONCOURSE SUITE 301 BAY HARBOR ISLANDS FL 33154 0 1 0 0 Chief Financial Officer COMMON STOCK, PAR VALUE $0.001 2022-11-30 4 P 0 5000 0.56 A 1402829 D Shares acquired as purchases made under the Issuer's Employee Stock Purchase Plan ("ESPP") during the ESPP offering period. Under the ESPP, 5,000 shares is the maximum amount an individual employee may purchase during an offering period. The total holdings include 1,350,000 shares underlying restricted stock units. /s/ David Jin 2022-12-02